Tissue implants for implantation and methods for preparing the same
View Patent ↗A method is provided for preparing a tissue implant for implantation. The method includes treating a pericardium tissue material, which has been harvested from a donor and rendered essentially acellular, with a chlorine dioxide treatment solution; and thereafter treating the pericardium tissue material with an antioxidant solution, which comprises ascorbic acid or a salt thereof.
1. A method of preparing a tissue implant for implantation comprising:
treating an essentially acellular tissue material with a chlorine dioxide treatment solution; and thereafter
treating the tissue material with an antioxidant-containing solution in an amount effective to degrade the chlorine dioxide, remaining in the tissue material following treatment with the chlorine dioxide treatment solution.
2. The method of claim 1 , wherein during treatment with the chlorine dioxide treatment solution, the chlorine dioxide treatment solution comprises greater than about 50 ppm chlorine dioxide for about 60 minutes or longer.
3. The method of claim 1 , wherein the concentration of chlorine dioxide in the chlorine dioxide treatment solution is about 100 ppm to about 160 ppm.
4. The method of claim 1 , wherein the antioxidant-containing solution comprises ascorbic acid or a salt thereof.
5. The method of claim 1 , wherein the antioxidant-containing solution comprises sodium ascorbate.
6. The method of claim 1 , wherein the antioxidant-containing solution comprises sodium ascorbate in a concentration of about 9.0 mM to about 11.0 mM.
7. The method of claim 1 , further comprising vacuum sealing the tissue material in a package with the antioxidant-containing solution.
8. The method of claim 7 , further comprising sterilizing the tissue material while the tissue material is in the package.
9. The method of claim 1 , wherein the tissue material comprises human, bovine or equine pericardium.
10. The method of claim 1 , wherein treatment of the tissue material provides at least a 10 log viral reduction.
11. The method of claim 1 , wherein the antioxidant-containing solution comprises butylhydroxytoluene or tocopherol.
12. A method of preparing a tissue implant for implantation comprising:
treating a pericardium tissue material, which has been harvested from a donor and rendered essentially acellular, with a chlorine dioxide treatment solution; and thereafter
treating the pericardium tissue material with an antioxidant solution, which comprises ascorbic acid or a salt thereof, to degrade the chlorine dioxide, remaining in the pericardium tissue material following treatment with the chlorine dioxide treatment solution.
13. The method of claim 12 , wherein the concentration of chlorine dioxide in the chlorine dioxide treatment solution is about 100 ppm to about 160 ppm and wherein the antioxidant comprises sodium ascorbate in a concentration of about 9.0 mM to about 11.0 mM.
14. The method of claim 12 , wherein during treatment with the chlorine dioxide solution, the chlorine dioxide treatment solution comprises greater than about 50 ppm chlorine dioxide for about 60 minutes or longer.
15. The method of claim 12 , wherein the treatment of the pericardium tissue material with the chlorine dioxide treatment solution comprises treating the pericardium tissue material with a chlorine dioxide treatment solution for one or more periods of about 60 to about 90 minutes.
16. The method of claim 12 , further comprising vacuum sealing the pericardium tissue material in a package with the antioxidant solution.
17. The method of claim 16 , further comprising sterilizing the pericardium tissue material while the pericardium tissue material is in the package.
18. The method of claim 17 , wherein sterilizing the pericardium tissue material comprises irradiating the pericardium tissue material.
19. The method of claim 12 , wherein treatment of the pericardium tissue material provides at least a 10 log viral reduction.
20. A method of preparing a tissue implant for implantation comprising:
treating a pericardium tissue material, which has been harvested from a donor and rendered essentially acellular, with a chlorine dioxide treatment solution; and thereafter
treating the pericardium tissue material with an antioxidant solution;
vacuum sealing the pericardium tissue material in a package with the antioxidant solution to form a packaged tissue material; and
sterilizing the packaged tissue material with ionizing radiation,
wherein the antioxidant solution is effective to degrade the chlorine dioxide, remaining in the pericardium tissue material following treatment with the chlorine dioxide treatment solution and/or to act as a radioprotectant during the sterilization.
21. The method of claim 20 , wherein the antioxidant solution comprises ascorbic acid, a salt of ascorbic acid, butylhydroxytoluene, tocopherol, or a combination thereof.